195 related articles for article (PubMed ID: 38180081)
21. Upregulation of adiponectin receptor 1 and 2 mRNA and protein in adipose tissue and adipocytes in insulin-resistant women with polycystic ovary syndrome.
Tan BK; Chen J; Digby JE; Keay SD; Kennedy CR; Randeva HS
Diabetologia; 2006 Nov; 49(11):2723-8. PubMed ID: 17001470
[TBL] [Abstract][Full Text] [Related]
22. Early initiation of anti-androgen treatment is associated with increased probability of spontaneous conception leading to childbirth in women with polycystic ovary syndrome: a population-based multiregistry cohort study in Sweden.
Elenis E; Desroziers E; Persson S; Sundström Poromaa I; Campbell RE
Hum Reprod; 2021 Apr; 36(5):1427-1435. PubMed ID: 33454768
[TBL] [Abstract][Full Text] [Related]
23. Evidence for masculinization of adipokine gene expression in visceral and subcutaneous adipose tissue of obese women with polycystic ovary syndrome (PCOS).
Martínez-García MÁ; Montes-Nieto R; Fernández-Durán E; Insenser M; Luque-Ramírez M; Escobar-Morreale HF
J Clin Endocrinol Metab; 2013 Feb; 98(2):E388-96. PubMed ID: 23337724
[TBL] [Abstract][Full Text] [Related]
24. Metabolism and insulin signaling in common metabolic disorders and inherited insulin resistance.
Højlund K
Dan Med J; 2014 Jul; 61(7):B4890. PubMed ID: 25123125
[TBL] [Abstract][Full Text] [Related]
25. Adipose tissue has aberrant morphology and function in PCOS: enlarged adipocytes and low serum adiponectin, but not circulating sex steroids, are strongly associated with insulin resistance.
Mannerås-Holm L; Leonhardt H; Kullberg J; Jennische E; Odén A; Holm G; Hellström M; Lönn L; Olivecrona G; Stener-Victorin E; Lönn M
J Clin Endocrinol Metab; 2011 Feb; 96(2):E304-11. PubMed ID: 21084397
[TBL] [Abstract][Full Text] [Related]
26. Characterization of reproductive, metabolic, and endocrine features of polycystic ovary syndrome in female hyperandrogenic mouse models.
Caldwell AS; Middleton LJ; Jimenez M; Desai R; McMahon AC; Allan CM; Handelsman DJ; Walters KA
Endocrinology; 2014 Aug; 155(8):3146-59. PubMed ID: 24877633
[TBL] [Abstract][Full Text] [Related]
27. Increased regulated on activation, normal T-cell expressed and secreted levels and cysteine-cysteine chemokine receptor 5 upregulation in omental adipose tissue and peripheral blood mononuclear cells are associated with testosterone level and insulin resistance in polycystic ovary syndrome.
Juan CC; Chen KH; Chen CW; Ho CH; Wang PH; Chen HS; Hwang JL; Lin YH; Seow KM
Fertil Steril; 2021 Oct; 116(4):1139-1146. PubMed ID: 34119324
[TBL] [Abstract][Full Text] [Related]
28. Mitochondrial function and oxidative stress in white adipose tissue in a rat model of PCOS: effect of SGLT2 inhibition.
Pruett JE; Everman SJ; Hoang NH; Salau F; Taylor LC; Edwards KS; Hosler JP; Huffman AM; Romero DG; Yanes Cardozo LL
Biol Sex Differ; 2022 Aug; 13(1):45. PubMed ID: 35986388
[TBL] [Abstract][Full Text] [Related]
29. Impaired insulin-stimulated phosphorylation of Akt and AS160 in skeletal muscle of women with polycystic ovary syndrome is reversed by pioglitazone treatment.
Højlund K; Glintborg D; Andersen NR; Birk JB; Treebak JT; Frøsig C; Beck-Nielsen H; Wojtaszewski JF
Diabetes; 2008 Feb; 57(2):357-66. PubMed ID: 17977950
[TBL] [Abstract][Full Text] [Related]
30. Non-cell autonomous mechanisms control mitochondrial gene dysregulation in polycystic ovary syndrome.
Moreno-Asso A; Altıntaş A; McIlvenna LC; Patten RK; Botella J; McAinch AJ; Rodgers RJ; Barrès R; Stepto NK
J Mol Endocrinol; 2021 Dec; 68(1):63-76. PubMed ID: 34752415
[TBL] [Abstract][Full Text] [Related]
31. Increased Skeletal Muscle Fiber Cross-Sectional Area, Muscle Phenotype Shift, and Altered Insulin Signaling in Rat Hindlimb Muscles in a Prenatally Androgenized Rat Model for Polycystic Ovary Syndrome.
DeChick A; Hetz R; Lee J; Speelman DL
Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33113794
[TBL] [Abstract][Full Text] [Related]
32. Increased visfatin messenger ribonucleic acid and protein levels in adipose tissue and adipocytes in women with polycystic ovary syndrome: parallel increase in plasma visfatin.
Tan BK; Chen J; Digby JE; Keay SD; Kennedy CR; Randeva HS
J Clin Endocrinol Metab; 2006 Dec; 91(12):5022-8. PubMed ID: 17003086
[TBL] [Abstract][Full Text] [Related]
33. Mechanisms Underlying Absent Training-Induced Improvement in Insulin Action in Lean, Hyperandrogenic Women With Polycystic Ovary Syndrome.
Hansen SL; Bojsen-Møller KN; Lundsgaard AM; Hendrich FL; Nilas L; Sjøberg KA; Hingst JR; Serup AK; Olguín CH; Carl CS; Wernblad LF; Henneberg M; Lustrup KM; Hansen C; Jensen TE; Madsbad S; Wojtaszewski JFP; Richter EA; Kiens B
Diabetes; 2020 Nov; 69(11):2267-2280. PubMed ID: 32873590
[TBL] [Abstract][Full Text] [Related]
34. Nontargeted metabolomic analysis of skeletal muscle in a dehydroepiandrosterone-induced mouse model of polycystic ovary syndrome.
Shen Q; Bi H; Yu F; Fan L; Zhu M; Jia X; Kang J
Mol Reprod Dev; 2019 Apr; 86(4):370-378. PubMed ID: 30633842
[TBL] [Abstract][Full Text] [Related]
35. Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome.
Pasquali R; Gambineri A; Biscotti D; Vicennati V; Gagliardi L; Colitta D; Fiorini S; Cognigni GE; Filicori M; Morselli-Labate AM
J Clin Endocrinol Metab; 2000 Aug; 85(8):2767-74. PubMed ID: 10946879
[TBL] [Abstract][Full Text] [Related]
36. Low-frequency electro-acupuncture and physical exercise improve metabolic disturbances and modulate gene expression in adipose tissue in rats with dihydrotestosterone-induced polycystic ovary syndrome.
Mannerås L; Jonsdottir IH; Holmäng A; Lönn M; Stener-Victorin E
Endocrinology; 2008 Jul; 149(7):3559-68. PubMed ID: 18388196
[TBL] [Abstract][Full Text] [Related]
37. Androgen Action in Adipose Tissue and the Brain are Key Mediators in the Development of PCOS Traits in a Mouse Model.
Cox MJ; Edwards MC; Rodriguez Paris V; Aflatounian A; Ledger WL; Gilchrist RB; Padmanabhan V; Handelsman DJ; Walters KA
Endocrinology; 2020 Jul; 161(7):. PubMed ID: 32301482
[TBL] [Abstract][Full Text] [Related]
38. Obesity, but not hyperandrogenism or insulin resistance, predicts skeletal muscle mass in reproductive-aged women with polycystic ovary syndrome: A systematic review and meta-analysis of 45 observational studies.
Kazemi M; Pierson RA; Parry SA; Kaviani M; Chilibeck PD
Obes Rev; 2021 Aug; 22(8):e13255. PubMed ID: 33855800
[TBL] [Abstract][Full Text] [Related]
39. Endothelial dysfunction in hyperandrogenic polycystic ovary syndrome is not explained by either obesity or ectopic fat deposition.
Sprung VS; Jones H; Pugh CJ; Aziz NF; Daousi C; Kemp GJ; Green DJ; Cable NT; Cuthbertson DJ
Clin Sci (Lond); 2014 Jan; 126(1):67-74. PubMed ID: 23826984
[TBL] [Abstract][Full Text] [Related]
40. Electroacupuncture Mimics Exercise-Induced Changes in Skeletal Muscle Gene Expression in Women With Polycystic Ovary Syndrome.
Benrick A; Pillon NJ; Nilsson E; Lindgren E; Krook A; Ling C; Stener-Victorin E
J Clin Endocrinol Metab; 2020 Jun; 105(6):2027-41. PubMed ID: 32232327
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
